Top

European Journal of Nutrition

Published in:

Open Access 01-08-2020 | Original Contribution

Beneficial effects of δ-tocotrienol against oxidative stress in osteoblastic cells: studies on the mechanisms of action

Authors: Lavinia Casati, Francesca Pagani, Patrizia Limonta, Claudia Vanetti, Giovanni Stancari, Valeria Sibilia

Published in: European Journal of Nutrition | Issue 5/2020

Abstract

Purpose

Natural antioxidants are considered as promising compounds in the prevention/treatment of osteoporosis. We studied the ability of purified δ-tocotrienol (δ-TT) isolated from a commercial palm oil (Elaeis guineensis) fraction to protect osteoblast MC3T3-E1 and osteocyte MLO-Y4 cells against tert-butyl hydroperoxide (t-BHP)-induced oxidative damage and the mechanisms involved in its protective action in MC3T3-E1.

Methods

MC3T3-E1 and MLO-Y4 cells were treated with δ-TT (1.25–20 µg/ml for 2 h) followed by t-BHP at 250 µM or 125 µM for 3 h, respectively. MTT test was used to measure cell viability. Apoptotic cells were stained with Hoechst-33258 dye. Intracellular ROS levels were measured by dichlorofluorescein CM-DCFA. The OPT fluorimetric assay was used to detect the reduced glutathione to oxidized glutathione ratio (GSH/GSSG) contents.

Results

δ-TT significantly prevented the effects of t-BHP on cell viability and apoptosis reaching a maximum protective activity at 10 and 5 µg/ml in MC3T3-E1 and MLO-Y4 cells, respectively. This protective effect was due to a reduction of intracellular ROS levels and an increase in the defense systems shown by the increase in the GSH/GSSG. GSH loss induced by an inhibitor of GSH synthesis significantly reduced the δ-TT-positive effect on ROS levels. δ-TT prevention of oxidative damage was completely removed by combined treatment with the specific inhibitors of PI3K/AKT (LY294002) and Nrf2 (ML385).

Conclusions

The δ-TT protective effect against oxidative damage in MC3T3-E1 cells is due to a reduction of intracellular ROS levels and an increase of the GSH/GSSG ratio, and involves an interaction between the PI3K/Akt–Nrf2 signaling pathways.

Domazetovic V, Marcucci G, Iantomasi T, Brandi ML, Vincenzini MT (2017) Oxidative stress in bone remodeling: role of antioxidants. Clin Cases Miner Bone Metab 14(2):209–216. https://doi.org/10.11138/ccmbm/2017.14.1.209 CrossRefPubMedPubMedCentral

Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR (1990) Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Investig 85(3):632–639. https://doi.org/10.1172/JCI114485 CrossRefPubMed

Lean JM, Jagger CJ, Kirstein B, Fuller K, Chambers TJ (2005) Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 146(2):728–735. https://doi.org/10.1210/en.2004-1021 CrossRefPubMed

Bai XC, Lu D, Liu AL, Zhang ZM, Li XM, Zou ZP, Zeng WS, Cheng BL, Luo SQ (2005) Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. J Biol Chem 280(17):17497–17506. https://doi.org/10.1074/jbc.M409332200 CrossRefPubMed

Almeida M, Han L, Martin-Millan M, Plotkin LI, Stewart SA, Roberson PK, Kousteni S, O’Brien CA, Bellido T, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC (2007) Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem 282(37):27285–27297. https://doi.org/10.1074/jbc.M702810200 CrossRefPubMedPubMedCentral

Casati L, Pagani F, Fibiani M, Lo Scalzo R, Sibilia V (2018) Potential of delphinidin-3-rutinoside extracted from Solanum melongena L. as promoter of osteoblastic MC3T3-E1 function and antagonist of oxidative damage. Eur J Nutr. https://doi.org/10.1007/s00394-018-1618-0 CrossRefPubMed

Banfi G, Iorio EL, Corsi MM (2008) Oxidative stress, free radicals and bone remodeling. Clin Chem Lab Med 46(11):1550–1555. https://doi.org/10.1515/CCLM.2008.302 CrossRefPubMed

Nojiri H, Saita Y, Morikawa D, Kobayashi K, Tsuda C, Miyazaki T, Saito M, Marumo K, Yonezawa I, Kaneko K, Shirasawa T, Shimizu T (2011) Cytoplasmic superoxide causes bone fragility owing to low-turnover osteoporosis and impaired collagen cross-linking. J Bone Miner Res 26(11):2682–2694. https://doi.org/10.1002/jbmr.489 CrossRefPubMed

Prasad G, Dhillon MS, Khullar M, Nagi ON (2003) Evaluation of oxidative stress after fractures. A preliminary study. Acta Orthop Belg 69(6):546–551PubMed

10.

Maggio D, Barabani M, Pierandrei M, Polidori MC, Catani M, Mecocci P, Senin U, Pacifici R, Cherubini A (2003) Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 88(4):1523–1527. https://doi.org/10.1210/jc.2002-021496 CrossRefPubMed

11.

Aggarwal BB, Sundaram C, Prasad S, Kannappan R (2010) Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem Pharmacol 80(11):1613–1631. https://doi.org/10.1016/j.bcp.2010.07.043 CrossRefPubMedPubMedCentral

12.

Ahmad NS, Khalid BA, Luke DA, Ima Nirwana S (2005) Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone. Clin Exp Pharmacol Physiol 32(9):761–770. https://doi.org/10.1111/j.1440-1681.2005.04264.x CrossRefPubMed

13.

Norazlina M, Hermizi H, Faizah O, Nazrun AS, Norliza M, Ima-Nirwana S (2010) Vitamin E reversed nicotine-induced toxic effects on bone biochemical markers in male rats. Arch Med Sci AMS 6(4):505–512. https://doi.org/10.5114/aoms.2010.14460 CrossRefPubMed

14.

Fujita K, Iwasaki M, Ochi H, Fukuda T, Ma C, Miyamoto T, Takitani K, Negishi-Koga T, Sunamura S, Kodama T, Takayanagi H, Tamai H, Kato S, Arai H, Shinomiya K, Itoh H, Okawa A, Takeda S (2012) Vitamin E decreases bone mass by stimulating osteoclast fusion. Nat Med 18(4):589–594. https://doi.org/10.1038/nm.2659 CrossRefPubMed

15.

Chin KY, Ima-Nirwana S (2014) The effects of alpha-tocopherol on bone: a double-edged sword? Nutrients 6(4):1424–1441. https://doi.org/10.3390/nu6041424 CrossRefPubMedPubMedCentral

16.

Soelaiman IN, Ming W, Abu Bakar R, Hashnan NA, Mohd Ali H, Mohamed N, Muhammad N, Shuid AN (2012) Palm tocotrienol supplementation enhanced bone formation in oestrogen-deficient rats. Int J Endocrinol 2012:532862. https://doi.org/10.1155/2012/532862 CrossRefPubMedPubMedCentral

17.

Deng L, Ding Y, Peng Y, Wu Y, Fan J, Li W, Yang R, Yang M, Fu Q (2014) Gamma-tocotrienol protects against ovariectomy-induced bone loss via mevalonate pathway as HMG-CoA reductase inhibitor. Bone 67:200–207. https://doi.org/10.1016/j.bone.2014.07.006 CrossRefPubMed

18.

Abdul-Majeed S, Mohamed N, Soelaiman IN (2012) Effects of tocotrienol and lovastatin combination on osteoblast and osteoclast activity in estrogen-deficient osteoporosis. Evid Based Complement Altern Med eCAM 2012:960742. https://doi.org/10.1155/2012/960742 CrossRef

19.

Chin KY, Ima-Nirwana S (2014) Effects of annatto-derived tocotrienol supplementation on osteoporosis induced by testosterone deficiency in rats. Clin Interv Aging 9:1247–1259. https://doi.org/10.2147/CIA.S67016 CrossRefPubMedPubMedCentral

20.

Mohamad NV, Ima-Nirwana S, Chin KY (2018) Effect of tocotrienol from Bixa orellana (annatto) on bone microstructure, calcium content, and biomechanical strength in a model of male osteoporosis induced by buserelin. Drug Des Dev Ther 12:555–564. https://doi.org/10.2147/DDDT.S158410 CrossRef

21.

Rondanelli M, Faliva MA, Peroni G, Moncaglieri F, Infantino V, Naso M, Perna S (2015) Focus on pivotal role of dietary intake (diet and supplement) and blood levels of tocopherols and tocotrienols in obtaining successful aging. Int J Mol Sci 16(10):23227–23249. https://doi.org/10.3390/ijms161023227 CrossRefPubMedPubMedCentral

22.

Peh HY, Tan WS, Liao W, Wong WS (2016) Vitamin E therapy beyond cancer: tocopherol versus tocotrienol. Pharmacol Ther 162:152–169. https://doi.org/10.1016/j.pharmthera.2015.12.003 CrossRefPubMed

23.

Shen CL, Klein A, Chin KY, Mo H, Tsai P, Yang RS, Chyu MC, Ima-Nirwana S (2017) Tocotrienols for bone health: a translational approach. Ann N Y Acad Sci 1401(1):150–165. https://doi.org/10.1111/nyas.13449 CrossRefPubMed

24.

Shen CL, Yang S, Tomison MD, Romero AW, Felton CK, Mo H (2018) Tocotrienol supplementation suppressed bone resorption and oxidative stress in postmenopausal osteopenic women: a 12-week randomized double-blinded placebo-controlled trial. Osteoporos Int 29(4):881–891. https://doi.org/10.1007/s00198-017-4356-x CrossRefPubMed

25.

Altman SA, Zastawny TH, Randers L, Lin ZL, Lumpkin JA, Remacle J, Dizdaroglu M, Rao G (1994) Tert-butyl hydroperoxide-mediated DNA-base damage in cultured-mammalian-cells. Mutat Res 306(1):35–44. https://doi.org/10.1016/0027-5107(94)90165-1 CrossRefPubMed

26.

Dieci E, Casati L, Pagani F, Celotti F, Sibilia V (2014) Acylated and unacylated ghrelin protect MC3T3-E1 cells against tert-butyl hydroperoxide-induced oxidative injury: pharmacological characterization of ghrelin receptor and possible epigenetic involvement. Amino Acids 46(7):1715–1725. https://doi.org/10.1007/s00726-014-1734-y CrossRefPubMed

27.

Bonewald LF (2011) The amazing osteocyte. J Bone Miner Res 26(2):229–238. https://doi.org/10.1002/jbmr.320 CrossRefPubMed

28.

Montagnani Marelli M, Marzagalli M, Moretti RM, Beretta G, Casati L, Comitato R, Gravina GL, Festuccia C, Limonta P (2016) Vitamin E delta-tocotrienol triggers endoplasmic reticulum stress-mediated apoptosis in human melanoma cells. Sci Rep 6:30502. https://doi.org/10.1038/srep30502 CrossRefPubMedPubMedCentral

29.

Casati L, Pagani F, Braga PC, Lo Scalzo R, Sibilia V (2016) Nasunin, a new player in the field of osteoblast protection against oxidative stress. J Funct Foods 23:474–484. https://doi.org/10.1016/j.jff.2016.03.007 CrossRef

30.

Hissin PJ, Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74(1):214–226CrossRef

31.

Shen J, Yang T, Xu Y, Luo Y, Zhong X, Shi L, Hu T, Guo T, Nie Y, Luo F, Lin Q (2018) delta-Tocotrienol, isolated from rice bran, exerts an anti-inflammatory effect via MAPKs and PPARs signaling pathways in lipopolysaccharide-stimulated macrophages. Int J Mol Sci. https://doi.org/10.3390/ijms19103022 CrossRefPubMedPubMedCentral

32.

Wang C, Husain K, Zhang A, Centeno BA, Chen DT, Tong Z, Sebti SM, Malafa MP (2015) EGR-1/Bax pathway plays a role in vitamin E delta-tocotrienol-induced apoptosis in pancreatic cancer cells. J Nutr Biochem 26(8):797–807. https://doi.org/10.1016/j.jnutbio.2015.02.008 CrossRefPubMedPubMedCentral

33.

Jones DP (2002) Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol 348:93–112CrossRef

34.

Griffith OW, Meister A (1979) Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J Biol Chem 254(16):7558–7560PubMed

35.

Li Q, Yin X, Wang W, Zhan M, Zhao B, Hou Z, Wang J (2016) The effects of buthionine sulfoximine on the proliferation and apoptosis of biliary tract cancer cells induced by cisplatin and gemcitabine. Oncol Lett 11(1):474–480. https://doi.org/10.3892/ol.2015.3879 CrossRefPubMed

36.

Romagnoli C, Marcucci G, Favilli F, Zonefrati R, Mavilia C, Galli G, Tanini A, Iantomasi T, Brandi ML, Vincenzini MT (2013) Role of GSH/GSSG redox couple in osteogenic activity and osteoclastogenic markers of human osteoblast-like SaOS-2 cells. FEBS J 280(3):867–879. https://doi.org/10.1111/febs.12075 CrossRefPubMed

37.

Song BL, DeBose-Boyd RA (2006) Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme a reductase stimulated by delta- and gamma-tocotrienols. J Biol Chem 281(35):25054–25061. https://doi.org/10.1074/jbc.M605575200 CrossRefPubMed

38.

Ruan F, Zheng Q, Wang J (2012) Mechanisms of bone anabolism regulated by statins. Biosci Rep 32(6):511–519. https://doi.org/10.1042/BSR20110118 CrossRefPubMedPubMedCentral

39.

Wang B, Shravah J, Luo H, Raedschelders K, Chen DD, Ansley DM (2009) Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation. Biochem Biophys Res Commun 389(1):105–111. https://doi.org/10.1016/j.bbrc.2009.08.097 CrossRefPubMedPubMedCentral

40.

Singh A, Venkannagari S, Oh KH, Zhang YQ, Rohde JM, Liu L, Nimmagadda S, Sudini K, Brimacombe KR, Gajghate S, Ma J, Wang A, Xu X, Shahane SA, Xia M, Woo J, Mensah GA, Wang Z, Ferrer M, Gabrielson E, Li Z, Rastinejad F, Shen M, Boxer MB, Biswal S (2016) Small molecule inhibitor of NRF2 selectively intervenes therapeutic resistance in KEAP1-deficient NSCLC tumors. ACS Chem Biol 11(11):3214–3225. https://doi.org/10.1021/acschembio.6b00651 CrossRefPubMedPubMedCentral

41.

Wan Hasan WN, Abd Ghafar N, Chin KY, Ima-Nirwana S (2018) Annatto-derived tocotrienol stimulates osteogenic activity in preosteoblastic MC3T3-E1 cells: a temporal sequential study. Drug Des Dev Ther 12:1715–1726. https://doi.org/10.2147/DDDT.S168935 CrossRef

42.

Abukhadir SS, Mohamed N, Makpol S, Muhammad N (2012) Effects of palm vitamin E on bone-formation-related gene expression in nicotine-treated rats. Evid Based Complement Altern Med eCAM 2012:656025. https://doi.org/10.1155/2012/656025 CrossRef

43.

Chin KY, Ima-Nirwana S (2015) The biological effects of tocotrienol on bone: a review on evidence from rodent models. Drug Des Dev Ther 9:2049–2060. https://doi.org/10.2147/Dddt.S79660 CrossRef

44.

Baur JA, Ungvari Z, Minor RK, Le Couteur DG, de Cabo R (2012) Are sirtuins viable targets for improving healthspan and lifespan? Nat Rev Drug Discov 11(6):443–461. https://doi.org/10.1038/nrd3738 CrossRefPubMedPubMedCentral

45.

McGonnell IM, Grigoriadis AE, Lam EW, Price JS, Sunters A (2012) A specific role for phosphoinositide 3-kinase and AKT in osteoblasts? Front Endocrinol 3:88. https://doi.org/10.3389/fendo.2012.00088 CrossRef

46.

Loboda A, Damulewicz M, Pyza E, Jozkowicz A, Dulak J (2016) Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci CMLS 73(17):3221–3247. https://doi.org/10.1007/s00018-016-2223-0 CrossRefPubMed

47.

Min KJ, Lee JT, Joe EH, Kwon TK (2011) An IkappaBalpha phosphorylation inhibitor induces heme oxygenase-1(HO-1) expression through the activation of reactive oxygen species (ROS)-Nrf2–ARE signaling and ROS-PI3K/Akt signaling in an NF-kappaB-independent mechanism. Cell Signal 23(9):1505–1513. https://doi.org/10.1016/j.cellsig.2011.05.013 CrossRefPubMed

48.

Greco T, Fiskum G (2010) Brain mitochondria from rats treated with sulforaphane are resistant to redox-regulated permeability transition. J Bioenerg Biomembr 42(6):491–497. https://doi.org/10.1007/s10863-010-9312-9 CrossRefPubMedPubMedCentral

49.

Greco T, Shafer J, Fiskum G (2011) Sulforaphane inhibits mitochondrial permeability transition and oxidative stress. Free Radic Biol Med 51(12):2164–2171. https://doi.org/10.1016/j.freeradbiomed.2011.09.017 CrossRefPubMedPubMedCentral

50.

Kobayashi M, Yamamoto M (2005) Molecular mechanisms activating the Nrf2–Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal 7(3–4):385–394. https://doi.org/10.1089/ars.2005.7.385 CrossRefPubMed

51.

Salazar M, Rojo AI, Velasco D, de Sagarra RM, Cuadrado A (2006) Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem 281(21):14841–14851. https://doi.org/10.1074/jbc.M513737200 CrossRefPubMed

52.

Kwak MK, Kensler TW (2010) Targeting NRF2 signaling for cancer chemoprevention. Toxicol Appl Pharmacol 244(1):66–76. https://doi.org/10.1016/j.taap.2009.08.028 CrossRefPubMed

53.

Han D, Chen W, Gu X, Shan R, Zou J, Liu G, Shahid M, Gao J, Han B (2017) Cytoprotective effect of chlorogenic acid against hydrogen peroxide-induced oxidative stress in MC3T3-E1 cells through PI3K/Akt-mediated Nrf2/HO-1 signaling pathway. Oncotarget 8(9):14680–14692. https://doi.org/10.18632/oncotarget.14747 CrossRefPubMedPubMedCentral

54.

Nakaso K, Yano H, Fukuhara Y, Takeshima T, Wada-Isoe K, Nakashima K (2003) PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells. FEBS Lett 546(2–3):181–184CrossRef

55.

Copple IM, Goldring CE, Kitteringham NR, Park BK (2008) The Nrf2–Keap1 defence pathway: role in protection against drug-induced toxicity. Toxicology 246(1):24–33. https://doi.org/10.1016/j.tox.2007.10.029 CrossRefPubMed

56.

Lee HR, Cho JM, Shin DH, Yong CS, Choi HG, Wakabayashi N, Kwak MK (2008) Adaptive response to GSH depletion and resistance to l-buthionine-(S,R)-sulfoximine: involvement of Nrf2 activation. Mol Cell Biochem 318(1–2):23–31. https://doi.org/10.1007/s11010-008-9853-y CrossRefPubMed

57.

Downward J (2004) PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol 15(2):177–182CrossRef

58.

Henriksen K, Neutzsky-Wulff AV, Bonewald LF, Karsdal MA (2009) Local communication on and within bone controls bone remodeling. Bone 44(6):1026–1033. https://doi.org/10.1016/j.bone.2009.03.671 CrossRefPubMed

59.

Verborgt O, Gibson GJ, Schaffler MB (2000) Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J Bone Miner Res 15(1):60–67. https://doi.org/10.1359/jbmr.2000.15.1.60 CrossRefPubMed

60.

Fontani F, Marcucci G, Iantomasi T, Brandi ML, Vincenzini MT (2015) Glutathione, N-acetylcysteine and lipoic acid down-regulate starvation-induced apoptosis, RANKL/OPG ratio and sclerostin in osteocytes: involvement of JNK and ERK1/2 signalling. Calcif Tissue Int 96(4):335–346. https://doi.org/10.1007/s00223-015-9961-0 CrossRefPubMed

61.

Bonewald LF, Johnson ML (2008) Osteocytes, mechanosensing and Wnt signaling. Bone 42(4):606–615. https://doi.org/10.1016/j.bone.2007.12.224 CrossRefPubMedPubMedCentral

62.

Qureshi AA, Karpen CW, Qureshi N, Papasian CJ, Morrison DC, Folts JD (2011) Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries. Lipids Health Dis 10:58. https://doi.org/10.1186/1476-511X-10-58 CrossRefPubMedPubMedCentral

63.

Gao P, Morozowich W (2006) Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Deliv 3(1):97–110. https://doi.org/10.1517/17425247.3.1.97 CrossRefPubMed

64.

Mahipal A, Klapman J, Vignesh S, Yang CS, Neuger A, Chen DT, Malafa MP (2016) Pharmacokinetics and safety of vitamin E delta-tocotrienol after single and multiple doses in healthy subjects with measurement of vitamin E metabolites. Cancer Chemother Pharmacol 78(1):157–165. https://doi.org/10.1007/s00280-016-3048-0 CrossRefPubMedPubMedCentral

65.

Springett GM, Husain K, Neuger A, Centeno B, Chen DT, Hutchinson TZ, Lush RM, Sebti S, Malafa MP (2015) A phase I safety, pharmacokinetic, and pharmacodynamic presurgical trial of vitamin E delta-tocotrienol in patients with pancreatic ductal neoplasia. EBioMedicine 2(12):1987–1995. https://doi.org/10.1016/j.ebiom.2015.11.025 CrossRefPubMedPubMedCentral

Title: Beneficial effects of δ-tocotrienol against oxidative stress in osteoblastic cells: studies on the mechanisms of action
Authors: Lavinia Casati
Francesca Pagani
Patrizia Limonta
Claudia Vanetti
Giovanni Stancari
Valeria Sibilia
Publication date: 01-08-2020
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nutrition / Issue 5/2020
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-019-02047-9

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Beneficial effects of δ-tocotrienol against oxidative stress in osteoblastic cells: studies on the mechanisms of action

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2020

Theabrownin from Pu-erh tea together with swinging exercise synergistically ameliorates obesity and insulin resistance in rats

Iodine status of teenage girls on the island of Ireland

Contribution of protein intake and its interaction with physical activity to transitions between disability states and to death in very old adults: the Newcastle 85+ Study

TMAO, creatine and 1-methylhistidine in serum and urine are potential biomarkers of cod and salmon intake: a randomised clinical trial in adults with overweight or obesity

Adherence to a food group-based dietary guideline and incidence of prediabetes and type 2 diabetes

Soy food and isoflavones are not associated with changes in serum lipids and glycohemoglobin concentrations among Japanese adults: a cohort study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page